Our CEO Roman Grunt was very proud to be a guest speaker at the First International Forum on Innovation and Research of Drugs for Cancer event, and share how QUINTA-ANALYTICA manages it’s clinical trials. We were excited and pleased to accompany so many internationally renowned experts from academia and industry, including the fantastic other guest speakers to discuss the latest progress in cancer research. Thank you Atengen, Inc. for inviting us to join you in Tianjin, China!

Additional News

  • 3 September 2026

    Quinta-Analytica Expands HPLC Fleet to Strengthen Flexibility and Capacity for Clients

    New Thermo Scientific Vanquish Core joins an HPLC fleet of around 50 systems

  • 7 August 2026

    Quinta-Analytica at CPHI Milan 2026 – Meet Us at Conscio Group Stand 6N25

    Meet Quinta-Analytica at CPHI Milan 2026 as part of the Conscio Group team at Stand 6N25. Discuss your clinical, bioanalytical and analytical projects with our experts and arrange a meeting in advance.

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.

ALL POSTS